AHEAD OF THE CURVE ®

Synthetic Biology 2.0: High-Growth Vertical Disrupting Many End Markets

Overview

Synthetic Biology (“SynBio”) is a high-growth vertical with the potential to unlock value across multiple industries. There are 4 platform types — tools 2.0, R&D engines with product development (lab-to-market), R&D engines that produce products (sharing economy), and products. SynBio products are entering many other verticals; a horizontal effect. We expect an acceleration of commercial successes and market penetration, especially as tools 3.0 plug in.

Contact

Headshot DB

Dierk
Beyer

Partner
M&A, Cowen

+49 69 5060 675 62
Email

Tobias
Levedag

Partner
M&A, Cowen

+49 89 2000 393 70
Email

Get Report

    Get the full report.

    Similar Insights

    Pharma Services Report April
    Insights Cowen Valued-Based Care Health Care Business Model Transformation